Company / PP&E (Net)
ARVINAS, INC. PP&E (Net) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$5.2M
FY2025
5-year range
$5.2M / $13.4M
FY2021-FY2025
Trend
-25.7%
vs FY2024
Sector context
#111 of 193
Health Care
What the data says
At $5M, ARVINAS, INC.'s pp&e (net) ranks #111 of 193 in the Health Care sector. PP&E (Net) has declined for 3 consecutive years, from $13M in FY2022 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -15.8%.
Declined from $12M to $5M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -27.1%
- 5-Year CAGR
- -15.8%
- 10-Year CAGR
- -
Sector benchmark
#111 of 193 in Health CareTop 58% of 193This company $5.2M Sector average $777.6M
▼
-99.3% below sector average
Key checks
Key Insights
- ARVINAS, INC.'s pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of -15.8%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 25.7% year-over-year.
- Ranks #111 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2M | -25.7% |
| FY2024 | $7.0M | -39.1% |
| FY2023 | $11.5M | -14.2% |
| FY2022 | $13.4M | +5.5% |
| FY2021 | $12.7M | +3.3% |
| FY2020 | $12.3M | +45.5% |
| FY2019 | $8.5M | +136.0% |
| FY2018 | $3.6M | +175.9% |
| FY2017 | $1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026